Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Polycomb repressive complex 2 (PRC2), composed of the core subunits EED, SUZ12, and either EZH1 or EZH2, is critical for maintaining cellular identity in multicellular organisms. PRC2 deposits H3K27me3, which is thought to recruit the canonical form of PRC1 (cPRC1) to promote gene repression. Here, we show that EZH1-PRC2 and cPRC1 are the primary Polycomb complexes on target genes in non-dividing, quiescent cells. Furthermore, these cells are resistant to PRC2 inhibitors. While PROTAC-mediated degradation of EZH1-PRC2 in quiescent cells does not reduce H3K27me3, it partially displaces cPRC1. Our results reveal an evolutionarily conserved switch to less catalytically active Polycomb complexes in non-dividing cells and raise concerns about using PRC2 inhibitors in cancers with significant populations of non-dividing cells.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11931288PMC
http://dx.doi.org/10.1016/j.celrep.2024.115192DOI Listing

Publication Analysis

Top Keywords

non-dividing cells
12
conserved switch
8
switch catalytically
8
catalytically active
8
active polycomb
8
polycomb repressive
8
complexes non-dividing
8
polycomb complexes
8
quiescent cells
8
prc2 inhibitors
8

Similar Publications

Focal segmental glomerulosclerosis (FSGS) is a common glomerular pathology characterized by podocyte injury, which can lead to kidney failure. Among the factors contributing to podocyte damage are mutations in nuclear pore complexes (NPCs), which regulate nuclear-cytoplasmic transport of proteins and RNAs. Defective NPCs can accumulate in highly differentiated, non-dividing cells such as podocytes.

View Article and Find Full Text PDF

Streptomycetes are biotechnologically valuable bacteria with complex cell division that produce extracellular vesicles (EVs), typically nanometre-sized but can reach 2.5 μm in diameter. Streptomyces also produce dividing wall-deficient L-forms (0.

View Article and Find Full Text PDF

Optimized chemical structure extends silencing duration of therapeutic siRNAs in dividing cancer and immune cells.

Mol Ther

August 2025

Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Otfried-Mueller-Strasse 10, 72076 Tuebingen, Germany; Gene and RNA Therapy Center (GRTC), Faculty of Medicine, University Tuebingen, Otfried-Mueller-Strasse 10, 72076 Tuebin

RNA interference (RNAi)-based medicines offer precise targeting of virtually any transcript, making them an appealing new drug class for immuno-oncology. While RNAi therapies are highly effective in non-dividing cells, their efficacy in rapidly dividing cells, crucial for immuno-oncology, remains largely unexplored. Previous data suggest that full chemical modification of short interfering RNAs (siRNAs) in dividing cells has not consistently extended silencing duration, unlike in non-dividing cells.

View Article and Find Full Text PDF

DNA Topoisomerase II Mutations in Cancer: Structural Impact and Drug Response in High-grade Serous Ovarian Carcinoma.

J Mol Biol

August 2025

Université de Strasbourg, Centre National de la Recherche Scientifique (CNRS), Institut national de la Recherche Médicale (INSERM), Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), UMR 7104-UMR-S 1258, F-67400 Illkirch, France; Department of Integrated Structural Biology,

Topoisomerases are essential enzymes that resolve DNA topological stress during replication and transcription. In mammalian cells, the two isoforms, TOP2A and TOP2B, differ in expression profiles and functions. TOP2A is a key regulator of cell division, mainly expressed in rapidly dividing cells, such as cancer cells, and is therefore the primary target of several chemotherapeutic molecules.

View Article and Find Full Text PDF

Emerging drivers of DNA repeat expansions.

Biochem Soc Trans

August 2025

Department of Biology, Tufts University, Medford, MA 02155, U.S.A.

Expansions of short tandem repeats (STRs) are the cause of a class of human hereditary disorders called repeat expansion diseases (REDs). Most REDs are neurodegenerative or neurodevelopmental diseases such as Huntington's disease, myotonic dystrophy, fragile X syndrome, and Friedreich's ataxia. Some common neurodegenerative diseases, including Alzheimer's and Parkinson's disease, have also been associated with STR expansions.

View Article and Find Full Text PDF